000 02963nam a22003375i 4500
001 80543
003 ES-MaUEC
005 20230207040309.0
007 cr nn 008mamaa
008 131220s2014 gw | s |||| 0|eng d
020 _a9783642410659
040 _aES-MaUEC
050 4 _aRC280.B8
_bC456 2014 EB
100 1 _aChinyama, Catherine N.
_988825
_0Local
245 1 0 _aBenign Breast Diseases :
_bRadiology - Pathology - Risk Assessment
_cby Catherine N. Chinyama
250 _a2nd ed. 2014
260 _aBerlin, Heidelberg
_bSpringer
_c2014
300 _a1 recurso en línea (XIX, 294 p.) 104 il., 85 il. col.
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
520 _aThe second edition of this book has been extensively revised and updated.There have been numerous scientific advances in the radiology, pathology and risk assessment of benign breast lesions since the publication of the first edition.The first edition concentrated on screen-detected lesions, which has since been rectified; new symptomatic and screen-detected lesions are discussed in the second edition and include: mastitis and breast abscesses, idiopathic granulomatous mastitis, diabetic mastopathy, phyllodes tumours, gynaecomastia and pseudoangiomatous stromal hyperplasia.The chapters on columnar cell lesions and mucocele-like lesions have been extensively updated.Âרere applicable, genetic analysis of the benign lesions, which is becoming part of personalised medicine in the field of breast cancer, has been included.The book also presents detailed analyses of the main models, such as the Gail Model, used to assess the subsequent risk of breast cancer in individuals. The current trend in the management of all cancers is preventative.Â{u04E3}reening mammography detects early curable cancers as well as indeterminate lesions, the latter of which are invariably pathologically benign.The author has collated important benign lesions and, based on peer-reviewed publications, has documented the relative risk of subsequent cancer to allow the patient and the clinician to implement preventative measures where possible.This book will therefore serve as an essential component of multidisciplinary management of patients with symptomatic and screen-detected benign breast lesions
942 _2lcc
_cLE
988 _aEBOOK, EBSPRINGER
650 7 _aMamas
_xCáncer
_0comprobar BNE19901364206
_2embne
_9182522
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-642-41065-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9783642410659
907 _a.b12882963
_b10-10-17
_c11-11-15
998 _am
_a_alco
_a_vill
_b17-03-17
_cm
_dz
_ek
_feng
_ggw
_h0
945 _aRC280.B8 C456 2014 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i1156278x
_z06-04-17
999 _c80543
_d80543
_x1